Bever CT Jr - Search Results

Year	Number of Results
1981	1
1982	1
1983	1
1984	1
1985	1
1986	1
1988	2
1989	2
1990	2
1991	3
1992	1
1993	1
1994	3
1995	2
1996	3
1997	2
1998	6
1999	2
2001	1
2002	1
2003	2
2005	2
2006	2
2007	2
2009	2
2010	6
2011	1
2012	3
2013	2
2014	2
2015	3
2016	5
2017	2
2018	1
2019	2
2020	1
2022	1
2023	1
2024	0

1

Cell-based delivery of brain-derived neurotrophic factor in experimental allergic encephalomyelitis.

Makar TK, Nimmagadda VK, Trisler D, Bever CT Jr. Makar TK, et al. Among authors: bever ct jr. J Interferon Cytokine Res. 2014 Aug;34(8):641-7. doi: 10.1089/jir.2013.0160. Epub 2014 Mar 6. J Interferon Cytokine Res. 2014. PMID: 24601738 Review.

2

SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.

Nimmagadda VK, Makar TK, Chandrasekaran K, Sagi AR, Ray J, Russell JW, Bever CT Jr. Nimmagadda VK, et al. Among authors: bever ct jr. J Neuroimmunol. 2017 Mar 15;304:29-34. doi: 10.1016/j.jneuroim.2016.07.007. Epub 2016 Jul 17. J Neuroimmunol. 2017. PMID: 27474445 Free PMC article. Review.

3

Practice improvement requires more than guidelines and quality measures.

Sigsbee B, Bever CT Jr, Jones LK Jr. Sigsbee B, et al. Among authors: bever ct jr. Neurology. 2016 Jan 12;86(2):188-93. doi: 10.1212/WNL.0000000000002116. Epub 2015 Oct 30. Neurology. 2016. PMID: 26519541 Review.

4

Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?

Bever CT Jr, Rosenberg GA. Bever CT Jr, et al. Neurology. 1999 Oct 22;53(7):1380-1. doi: 10.1212/wnl.53.7.1380. Neurology. 1999. PMID: 10534237 Review. No abstract available.

5

Patients with clinically isolated syndromes suggestive of MS: does MRI allow earlier diagnosis?

Giovannoni G, Bever CT Jr. Giovannoni G, et al. Among authors: bever ct jr. Neurology. 2003 Jan 14;60(1):6-7. doi: 10.1212/wnl.60.1.6. Neurology. 2003. PMID: 12525709 No abstract available.

6

Prognosis of ocular myasthenia.

Bever CT Jr, Aquino AV, Penn AS, Lovelace RE, Rowland LP. Bever CT Jr, et al. Ann Neurol. 1983 Nov;14(5):516-9. doi: 10.1002/ana.410140504. Ann Neurol. 1983. PMID: 6651238

7

Novel use of existing technology: A preliminary study of patient portal use for telerehabilitation.

Conroy SS, Harcum S, Keldsen L, Bever CT Jr. Conroy SS, et al. Among authors: bever ct jr. J Telemed Telecare. 2022 Jun;28(5):380-388. doi: 10.1177/1357633X20950172. Epub 2020 Sep 1. J Telemed Telecare. 2022. PMID: 32869689

8

The current status of studies of aminopyridines in patients with multiple sclerosis.

Bever CT Jr. Bever CT Jr. Ann Neurol. 1994;36 Suppl:S118-21. doi: 10.1002/ana.410360728. Ann Neurol. 1994. PMID: 8017870 Review.

9

Quality indicators for multiple sclerosis.

Cheng EM, Crandall CJ, Bever CT Jr, Giesser B, Haselkorn JK, Hays RD, Shekelle P, Vickrey BG. Cheng EM, et al. Among authors: bever ct jr. Mult Scler. 2010 Aug;16(8):970-80. doi: 10.1177/1352458510372394. Epub 2010 Jun 18. Mult Scler. 2010. PMID: 20562162 Free PMC article.

10

Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment.

Judge SI, Bever CT Jr. Judge SI, et al. Among authors: bever ct jr. Pharmacol Ther. 2006 Jul;111(1):224-59. doi: 10.1016/j.pharmthera.2005.10.006. Epub 2006 Feb 9. Pharmacol Ther. 2006. PMID: 16472864 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year